Mindmed announces project angie, targeting the treatment of pain with psychedelics

New york, may 5, 2021 /prnewswire/ -- mind medicine (mindmed) inc. ("mindmed" or the "company") (nasdaq: mnmd) (neo: mmed), (de: mmq), a leading psychedelic-inspired medicine company announces the launch of its project angie to advance the development of psychedelics, including lsd, to treat pain conditions. mindmed is currently exploring two primary clinical indications for the treatment of pain.
MNMD Ratings Summary
MNMD Quant Ranking